AdaptHealth Corp. $AHCO Shares Sold by Intech Investment Management LLC

Intech Investment Management LLC decreased its holdings in AdaptHealth Corp. (NASDAQ:AHCO) by 61.1% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 109,108 shares of the company’s stock after selling 171,206 shares during the quarter. Intech Investment Management LLC owned approximately 0.08% of AdaptHealth worth $977,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Assetmark Inc. lifted its holdings in AdaptHealth by 87.6% during the 2nd quarter. Assetmark Inc. now owns 5,529 shares of the company’s stock worth $52,000 after buying an additional 2,581 shares during the last quarter. Tower Research Capital LLC TRC boosted its holdings in shares of AdaptHealth by 318.0% in the 2nd quarter. Tower Research Capital LLC TRC now owns 9,592 shares of the company’s stock valued at $90,000 after buying an additional 7,297 shares during the period. Tidal Investments LLC bought a new stake in shares of AdaptHealth during the 2nd quarter valued at about $96,000. Cerity Partners LLC bought a new stake in shares of AdaptHealth during the 2nd quarter valued at about $104,000. Finally, GSA Capital Partners LLP acquired a new stake in AdaptHealth during the third quarter worth about $103,000. Hedge funds and other institutional investors own 82.67% of the company’s stock.

AdaptHealth Stock Performance

AHCO opened at $9.49 on Monday. The company has a market capitalization of $1.29 billion, a price-to-earnings ratio of -17.25, a price-to-earnings-growth ratio of 1.09 and a beta of 1.76. The company has a debt-to-equity ratio of 1.15, a current ratio of 1.02 and a quick ratio of 0.81. AdaptHealth Corp. has a 1-year low of $7.11 and a 1-year high of $11.17. The business has a 50 day moving average price of $10.11 and a two-hundred day moving average price of $9.66.

AdaptHealth (NASDAQ:AHCO) last issued its quarterly earnings results on Tuesday, February 24th. The company reported ($0.76) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.34 by ($1.10). The firm had revenue of $846.29 million for the quarter, compared to analyst estimates of $832.51 million. AdaptHealth had a negative net margin of 2.18% and a positive return on equity of 3.42%. The firm’s revenue for the quarter was down 1.2% compared to the same quarter last year. During the same quarter last year, the business posted $0.34 earnings per share. Research analysts predict that AdaptHealth Corp. will post 0.88 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on AHCO shares. Weiss Ratings lowered shares of AdaptHealth from a “hold (c-)” rating to a “sell (d)” rating in a research report on Wednesday, February 25th. Zacks Research upgraded shares of AdaptHealth from a “strong sell” rating to a “hold” rating in a research report on Thursday, January 1st. Royal Bank Of Canada reissued an “outperform” rating and set a $13.00 target price on shares of AdaptHealth in a research note on Wednesday, February 25th. Wall Street Zen lowered shares of AdaptHealth from a “buy” rating to a “hold” rating in a research note on Saturday, February 28th. Finally, Leerink Partners cut their price target on AdaptHealth from $13.00 to $12.00 and set an “outperform” rating on the stock in a report on Thursday, February 26th. Four analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $13.25.

AdaptHealth Company Profile

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.